New Weapon In The Fight Against Parkinson's Disease - NAC Supplementation - Read by Christos Sierros

NEW YORK - June 23, 2019 - PRLog -- Thomas Jefferson University researchers had revealed in the past that patient use of of N-acetyl-cysteine (NAC) boosted dopamine metabolism in dopamine-producing neurons in the brain area which experiences substantial damage due to Parkinson's disease. Their research also found motor symptoms to have benefited by NAC use.

The researchers recently studied whether NAC use boosts dopamine-related brain function and lessens Parkinson's symptomatology in a larger trial group than the original 23-participant trial. Researchers found that NAC use substantially boosted dopamine transporter binding (whose levels may drop up to 70% in Parkinson's patients) in the putamen and caudate,  the main brain areas that control the movement of the body.  Moreover, participants who took NAC exhibited a substantial reduction in motor- & non-motor-related symptoms.

The research trials' findings indicate that NAC use by participants with Parkinson's disease leads to boosted dopamine transporter binding, and consequently a reduction in the disease's motor- & non-motor-related symptoms

About N-acetyl-cysteine (NAC)

NAC is an antioxidant precursor of cysteine. The consumption of cysteine and NAC is crucial to everyone's well-being, because they help with the production of glutathione, the most powerful antioxidant inside our bodies.

About Dopamine

Dopamine functions as a neurotransmitter, which transmits signals from one neuron to another, and is crucial for muscle movement & coordination. During Parkinson's disease spread, neurons which produce dopamine start dying out, resulting in the gradual reduction of dopamine levels.

Read by Christos Sierros (https://www.facebook.com/ChristosSierros)